<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
x

Response to Checkpoint Inhibition by GEMM Breast Cancer Allograft

Response to immunotherapy (I/O, e.g. to checkpoint inhibitors) in cancer patients, differs greatly, likely due to their genetic composition (e.g. neo-mutation) or to the immunological profile of their tumors.